Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant
Clinical trial NCT03883906 · COMPLETED
Trial details
- NCT number
- NCT03883906
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-16
- Primary completion
- 2020-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.